Called to Account: The last days of Theranos — the financials were as overhyped as the blood tests
It was the accountants, not the scientists, who were left with no choice but to deliver a bitter pill to the Theranos bo...
It was the accountants, not the scientists, who were left with no choice but to deliver a bitter pill to the Theranos bo...
U.S. stocks fought back from early losses sparked by a steep drop retail sales.
The S&P 500 and Dow ended down slightly on Thursday as gains in Apple and Amazon were offset by losses in energy and fin...
(Reuters) - U.S. stocks further extended gains on Friday, as Nike shares hit an all-time high after the world's lar...
(Reuters) - U.S. stocks jumped on Friday, boosted by a surge in Nike on its strong earnings report and as banking stocks...
NEW YORK (Reuters) - U.S. stocks rose on Thursday, as losses in shares of healthcare companies, battered by Amazon'...
(Reuters) - U.S. stocks opened higher on Friday with the Dow ending its 8-day losing streak as bank stocks gained after...
NEW YORK (Reuters) - The rising tensions over global trade policy are prompting some top-performing international fund m...